Aug. 9 at 12:33 AM
$OTLK they are a single product company with a lean workforce and 12 years of market exclusivity in an
$8.5B market having fully outsourced their logistics warehousing and distribution to Cencora. Their leadership team consists of veteran M&A executives who have previously directed multi billion dollar buyouts. Why hire Joel Prieve as senior vp of licensing and M&A to manage routine sales. Also Laura Cantrell the vp of corporate strategy and business development previously served on the core team managing pfizers
$14B buyout of Medivation. Finally chief legal officer Jennifer Couture who was promoted right after fda approval brings elite M&A credentials after previously directing AstraZenecas
$39B acquisition of Alexion.
So yes it's a real possibility.
